Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel-resistant prostate cancer cells (PC-3/R and DU-145/R)

被引：0
|
作者：
Surmeli, Zeki
Bozkurt, Emir
Ozer, Ozge
Atmaca, Harika
Kisim, Asli
Uzunoglu, Selim
Uslu, Ruchan
Karaca, Burcak
机构：
[1] Ege Univ, Tulay Aktas Oncol Hosp, Dept Med Oncol, Izmir, Turkey
[2] Celal Bayar Univ, Fac Sci & Letters, Dept Mol Biol, Manisa, Turkey
[3] Celal Bayar Univ, Sch Med, Dept Med Biol, Manisa, Turkey
[4] Ege Univ, Dept Med Oncol, Izmir, Turkey
[5] Ege Univ, Tulay Aktas Oncol Hosp, Sch Med, Izmir, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e16105
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16105
引用
收藏
页数：1
相关论文
共 50 条
  • [1] γ-Tocotrienol and α-Tocopheryloxyacetic Acid Increase the Effectiveness of Docetaxel Treatment of PC-3 Prostate Cancer Cells and Docetaxel-resistant PC-3 Cells
    Asay, Spencer
    Graham, Andrew
    Oblad, Richard
    Kenealey, Jason
    [J]. FASEB JOURNAL, 2019, 33
  • [2] Evaluation of Docetaxel-Sensitive and Docetaxel-Resistant Proteomes in PC-3 Cells
    Zu, Shulu
    Ma, Weiming
    Xiao, Pan
    Cui, Yazhou
    Ma, Tianjia
    Zhou, Chunwen
    Zhang, Huaiqiang
    [J]. UROLOGIA INTERNATIONALIS, 2015, 95 (01) : 114 - 119
  • [3] Cytotoxic and anti-angiogenic effects of zoledronic acid in DU-145 and PC-3 prostate cancer cell lines
    Cenk Gokalp
    [J]. Molecular Biology Reports, 2020, 47 : 7675 - 7683
  • [4] Cytotoxic and anti-angiogenic effects of zoledronic acid in DU-145 and PC-3 prostate cancer cell lines
    Gokalp, Cenk
    [J]. MOLECULAR BIOLOGY REPORTS, 2020, 47 (10) : 7675 - 7683
  • [5] Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines
    Varol, Umut
    Degirmenci, Mustafa
    Karaca, Burcak
    Atmaca, Harika
    Kisim, Asli
    Uzunoglu, Selim
    Sezgin, Canfeza
    Sanli, Ulus Ali
    Uslu, Ruchan
    [J]. TUMOR BIOLOGY, 2015, 36 (02) : 779 - 786
  • [6] Nobiletin suppresses cell viability through AKT Pathways in PC-3 and DU-145 prostate cancer cells
    Jianchu Chen
    Ashley Creed
    Allen Y Chen
    Haizhi Huang
    Zhaoliang Li
    Gary O Rankin
    Xingqian Ye
    Guihua Xu
    Yi Charlie Chen
    [J]. BMC Pharmacology and Toxicology, 15
  • [7] Nobiletin suppresses cell viability through AKT Pathways in PC-3 and DU-145 prostate cancer cells
    Chen, Jianchu
    Creed, Ashley
    Chen, Allen Y.
    Huang, Haizhi
    Li, Zhaoliang
    Rankin, Gary O.
    Ye, Xingqian
    Xu, Guihua
    Chen, Yi Charlie
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2014, 15 : 59
  • [8] Prazosin but Not Tamsulosin Sensitises PC-3 and LNCaP Prostate Cancer Cells to Docetaxel
    Spencer, Briohny H.
    McDermott, Catherine M.
    Chess-Williams, Russ
    Christie, David
    Anoopkumar-Dukie, Shailendra
    [J]. PHARMACOLOGY, 2018, 102 (1-2) : 17 - 25
  • [9] Bisphosphonates decrease hTERT in PC3 and DU-145 prostate cancer cells
    Bertoldo, Francesco
    Valenti, Maria Teresa
    Carbonare, Luca Dalle
    Azzarello, Giuseppe
    Balducci, Elena
    Zanatta, Mirko
    Zenari, Sonia
    Lo Cascio, Vincenzo
    Vinante, Orazio
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 33 - 33
  • [10] The potential cytotoxic effects of Valeriana officinalis extract on prostate cancer cell lines DU-145 and PC-3
    Aydin, F.
    Dikmen, B. Yurdakok
    Kismali, G.
    [J]. TOXICOLOGY LETTERS, 2016, 258 : S299 - S299
12345